A systematic quality rating of available mobile health apps for borderline personality disorder.
Lena Sophia SteublJosephin ReimannLaura SimonYannik TerhorstMichael StachHarald BaumeisterLasse Bosse SanderEva-Maria MessnerPublished in: Borderline personality disorder and emotion dysregulation (2022)
Available MHAs for BPD vary in quality and evidence on their efficacy, effectiveness, and possible adverse events is scarce. More substantial efforts to ensure the quality of MHAs available for patients and a focus on transparency, particularly regarding privacy and security documentation, are necessary.
Keyphrases
- end stage renal disease
- quality improvement
- newly diagnosed
- ejection fraction
- borderline personality disorder
- randomized controlled trial
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- healthcare
- machine learning
- big data
- public health
- electronic health record
- social media
- deep learning
- artificial intelligence